SCHEMBL1481741

SCHEMBL1481741

CCCCn1cc(-c2ccc(Cl)cc2Cl)nc1/C=C/c1ccc(OC)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 3/20 0.43
CRHR1 P34998 1/20 0.40
RELA Q04206 1/20 0.39
AHR P35869 2/20 0.39
CXCR2 P25025 1/20 0.39
FLT3 P36888 3/20 0.39
DPP4 P27487 2/20 0.38
DPP8 Q6V1X1 2/20 0.38
DPP9 Q86TI2 2/20 0.38
MAPT P10636 3/20 0.37
ALDH1A1 P00352 2/20 0.37
LMNA P02545 2/20 0.37
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
PKM P14618 1/20 0.37
RAB9A P51151 1/20 0.37
CDK5 Q00535 1/20 0.37
PAX8 Q06710 1/20 0.37
CDK5R1 Q15078 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1481743 1.00 TLR8 (0.43) TLR8CRHR1RELAAHRCXCR2
SCHEMBL1481899 0.97 TLR8 (0.43) TLR8CRHR1RELAAHRCXCR2
SCHEMBL1481901 0.97 TLR8 (0.43) TLR8CRHR1RELAAHRCXCR2
SCHEMBL1481407 0.92 ATP4A (0.45) TLR8AHRMAPTLMNAKDM4E
SCHEMBL1481410 0.92 ATP4A (0.45) TLR8AHRMAPTLMNAKDM4E
SCHEMBL1480852 0.91 DPP4 (0.42) TLR8CRHR1RELAAHRCXCR2
SCHEMBL1480849 0.91 DPP4 (0.42) TLR8CRHR1RELAAHRCXCR2
SCHEMBL1480782 0.90 RELA (0.42) RELAAHRCXCR2FLT3DPP4
SCHEMBL1480780 0.90 RELA (0.42) RELAAHRCXCR2FLT3DPP4
SCHEMBL1480190 0.87 DPP4 (0.43) RELAAHRCXCR2DPP4DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110077399-A1 Substituted Azole Derivatives as Therapeutic Agents TRANSTECH PHARMA, INC. (US) 2011-03-31 US disclosed
US-20110077399-A1 Substituted Azole Derivatives as Therapeutic Agents TRANSTECH PHARMA, INC. (US) 2011-03-31 US disclosed
US-20110077399-A1 Substituted Azole Derivatives as Therapeutic Agents TRANSTECH PHARMA, INC. (US) 2011-03-31 US disclosed
US-20040192743-A1 Substituted azole derivatives as therapeutic agents TRANSTECH PHARMA, INC. 2004-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192743-A1 Substituted azole derivatives as therapeutic agents PTPRS, PTPRO, PTPRJ TLR8 2695/4885CRHR1 4320/4885RELA 3971/4885
US-20110077399-A1 Substituted Azole Derivatives as Therapeutic Agents PTPRS, PTPRO, PTPRJ TLR8 2695/4885CRHR1 4320/4885RELA 3971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.